← Eichor
Study identifier: NCT07452120 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery

Condition: Hip Arthroplasty · Postoperative Pain · Regional Anesthesia  ·  Sponsor: Sivas Numune Hospital

PhaseNA
Planned participants70
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This randomized, double-blind clinical trial aims to compare the effectiveness of the Deep Iliacus Plane Block (DIPB) and the Suprainguinal Fascia Iliaca Block (SIFIB) for postoperative pain control in patients undergoing primary total hip arthroplasty. Effective analgesia after hip surgery is essential for early mobilization, reduction of complications, and improved recovery outcomes. Seventy patients scheduled for elective hip arthroplasty under spinal anesthesia will be randomly assigned to receive either DIPB or SIFIB at the end of surgery. Postoperative pain scores, opioid consumption, motor block, and block-related complications will be evaluated over a 48-hour period. The study aims to determine whether DIPB provides superior or comparable analgesia with reduced motor blockade compared to SIFIB, thereby contributing to safer and more comprehensive postoperative pain management in hip surgery patients.

This description comes directly from the study's public registry record.

Talk to the study team

Fatih Balcı, MD  ·  +90 545 864 76 57  ·  fatihbalci05@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Sivas Numune HospitalSivas, Sivas, Turkey (Türkiye)Not Yet Recruiting
Sivas Numune HospitalSivas, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07452120